article thumbnail

New portable PET scanner tested in humans

AuntMinnie

Conversely, recently developed portable PET scanners include seated or standing configurations and have been proposed for use in combat zones, sports fields, and intensive care units, the researchers added. In 2018, the group received a grant from the U.S. A link to the full study can be found here.

article thumbnail

First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies

Imaging Technology

Further information available at clinicaltrials.gov - ClinicalTrials.gov Identifier: NCT05629689 - A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies 3. Fruhwirth, G. Kneilling, M., De Vries, I. Weigelin, B., Srinivas, M., & Aarntzen, E.

article thumbnail

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

[iii] Based on orders data of GE HealthCare PET/CT systems since 2010. [iv] Measurement follows NEMA NU 2-2018. [v] v] Up to 53% reduction of PET scan time on Omni Legend 32 cm compared to Discovery MI 25 cm, as demonstrated in phantom testing. [vi] iv] Omni Legend 32 cm has up to 2.2 ix Mehranian, A., Walker, M.D.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

article thumbnail

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Imaging Technology

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

article thumbnail

AI Could Help Doctors Diagnose Lung Cancer Earlier

Imaging Technology

Keith Hewett, 64 from Watford, was diagnosed with lung cancer in 2018 and treated with surgery at his local hospital. Last year, a CT scan revealed nodules in Keith’s lung, and, after further investigation, he was diagnosed with cancer again. size, location, spiculation status), but also includes PET scan findings.